📖

Dementia Australia

active

wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-dementia-australia

Related Entities

institutions-dementia-australia

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

387

Outgoing

210

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Linked Artifacts (595)

see_also📖SYNGR3 Gene60%

see_also📖cognitive-reserve-cbs-psp60%

see_also📖ndrg260%

see_also📖Lysosomal Dysfunction in Progressive Supranuclear Palsy60%

see_also📖A/T/N+ Comprehensive Biomarker Panel for Alzheimer's Di60%

see_also📖vti1b60%

see_also📖DKK1 — Dickkopf WNT Signaling Pathway Inhibitor 160%

see_also📖Heme Oxygenase-1 (HO-1)60%

see_also📖Oligodendroglial Involvement in Progressive Supranuclear Pal60%

see_also📖SLC1A2 — Solute Carrier Family 1 Member 2 (EAAT2)60%

see_also📖neflamapimod-psp60%

see_also📖LZTS1 — Leucine Zipper Tumor Suppressor 160%

see_also📖SIGLEC9 — Sialic Acid Binding Ig-Like Lectin 960%

see_also📖section-186-crispr-base-editing-therapeutics-cbs-psp60%

see_also📖TAF15 Gene60%

see_also📖Disease-Associated Microglia in Alzheimer's Disease60%

see_also📖HDAC4 Gene60%

see_also📖Infectious Etiology Hypotheses in Alzheimer's Disease60%

see_also📖Bilingualism Cognitive Reserve AD Trial60%

see_also📖transcranial-sonography-cbs-psp60%

see_also📖SLC24A2 — Solute Carrier Family 2 Member 4A2 (SLC24A2)60%

see_also📖SLC17A6 Gene60%

see_also📖ABCD3 Gene60%

see_also📖Glymphatic System in Alzheimer's Disease60%

see_also📖AMDX-2011P Retinal Amyloid Tracer in Alzheimer's Diseas60%

see_also📖Glutamate Decarboxylase 160%

see_also📖proteins-hnrnpa2b1-protein60%

see_also📖Vascular and Endothelial Dysfunction in Progressive Supranuc60%

see_also📖DDX1 Gene60%

see_also📖HEXB Gene - Hexosaminidase Beta60%

see_also📖BAG1 Gene60%

see_also📖WNT5A Gene60%

see_also📖Pedunculopontine Nucleus Cholinergic in Progressive Supranuc60%

see_also📖RAB7L1 (RAB7 Like 1)60%

see_also📖RBPJL — Recombination Binding Protein Lambda60%

see_also📖Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD)60%

see_also📖section-239-advanced-light-therapy-photobiomodulation-cbs-ps60%

see_also📖NT5E Protein60%

see_also📖GRIN2A Protein60%

see_also📖ELAVL4 Gene60%

see_also📖dlb-rbd-autonomic-progression60%

see_also📖RNA Metabolism Dysregulation in Alzheimer's Disease60%

see_also📖PKM2 Metabolic Dysregulation in Alzheimer's Disease60%

see_also📖UCHL1 Gene60%

see_also📖Polysomnography and Sleep Study Testing for Atypical Parkins60%

see_also📖Red Nucleus Psp60%

see_also📖Lecanemab CLARITY-AD Trial60%

see_also📖Gosuranemab (BIIB092) PSP Trial60%

see_also📖Computational Tau Spreading Models in Progressive Supranucle60%

see_also📖Heat Shock Protein Dysfunction in Progressive Supranuclear P60%

see_also📖PDE4D Gene60%

see_also📖Layer 2 Entorhinal Cortex Neurons in Early Alzheimer's 60%

see_also📖section-209-glp-1-receptor-agonists-cbs-psp60%

see_also📖NDP52 Gene60%

see_also📖NLRP6 - NLR Family Pyrin Domain Containing 660%

see_also📖NADAPT Study: NAD Replenishment Therapy for Atypical Parkins60%

see_also📖TLR3 — Toll-Like Receptor 360%

see_also📖NRXN2 Gene60%

see_also📖DLB Cholinergic Dysfunction Mechanisms60%

see_also📖mitochondrial-dysfunction-ad60%

see_also📖NBR1 Gene60%

see_also📖section-197-advanced-clinical-trial-design-cbs-psp60%

see_also📖DLB Cognitive Fluctuation Mechanism Experiment60%

see_also📖Lecanemab CLARITY Open-Label Extension60%

see_also📖OPTN — Optineurin60%

see_also📖Lithium Carbonate PSP Trial60%

see_also📖Cortical Layer 5 Pyramidal Neurons in Alzheimer's Disea60%

see_also📖Methylphenidate + iTBS for Apathy in AD (PRIME Trial)60%

see_also📖GRIA3 Gene60%

see_also📖Stathmin-1 Protein60%

see_also📖ano960%

see_also📖tetrabenazine-psp60%

see_also📖PSP Japan — 日本PSP協会60%

see_also📖Metabolic Imaging and PET Tracers in CBS/PSP60%

see_also📖ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 260%

see_also📖PSP Germany60%

see_also📖CHMP2A60%

see_also📖section-228-advanced-dance-movement-therapy-cbs-psp60%

see_also📖Neurotransmitter Dysfunction in Progressive Supranuclear Pal60%

see_also📖HNRNPA2B1 Protein60%

see_also📖Ribosomal and Translation Dysfunction in Progressive Supranu60%

see_also📖CAR-A (Chimeric Antigen Receptor) Astrocyte Therapy for Alzh60%

see_also📖Stathmin-2 Protein60%

see_also📖Whole Genome Sequencing for CBS/PSP60%

see_also📖Salivary Biomarkers in Corticobasal Syndrome60%

see_also📖PSP Italy — Associazione Italiana PSP60%

see_also📖NOTCH3 Protein60%

see_also📖STAU2 Gene60%

see_also📖Accelerating Medicines Partnership for Alzheimer's Dise60%

see_also📖Personalized Antisense Oligonucleotide (ASO) Therapy60%

see_also📖NPM1 Gene60%

see_also📖combination-therapy-cbs-psp60%

see_also📖G3BP160%

see_also📖Accelerating Medicines Partnership Alzheimer's Disease 60%

see_also📖Locus Coeruleus Noradrenergic Neurons in Alzheimer's Di60%

see_also📖DLB Treatment Response Biomarkers — Predicting Cholinesteras60%

see_also📖PMP22 — Peripheral Myelin Protein 2260%

see_also📖Infectious Triggers in Alzheimer's Disease60%

see_also📖SGK3 - Serum/Glucocorticoid Regulated Kinase 360%

see_also📖NLGN1 Gene60%

see_also📖Metabolomic Alterations in Progressive Supranuclear Palsy60%

see_also📖NLRP6 Protein (NACHT, LRR and PYD Domains-Containing Protein60%

see_also📖entities-fus60%

see_also📖SQSTM1 — Sequestosome 1 (p62)60%

see_also📖FHL1 Gene60%

see_also📖TPN-101 for Progressive Supranuclear Palsy60%

see_also📖stathmin60%

see_also📖lecanemab60%

see_also📖Locus Coeruleus Noradrenergic in Progressive Supranuclear Pa60%

see_also📖HEXA Gene - Hexosaminidase Alpha60%

see_also📖Integrated Stress Response in Alzheimer's Disease60%

see_also📖Nigral Dopamine Neurons in Dementia with Lewy Bodies60%

see_also📖Glia-Neuron Crosstalk in Alzheimer's Disease60%

see_also📖PDE4C — Phosphodiesterase 4C60%

see_also📖MAP1LC3A Gene60%

see_also📖ENDOG60%

see_also📖lipid-metabolism-psp60%

see_also📖ABCA7 (Redirect)60%

see_also📖NIO752 Tau ASO PSP Trial60%

see_also📖section-198-advanced-precision-medicine-implementation-cbs-p60%

see_also📖TNFSF12 Gene (TWEAK)60%

see_also📖MK-1167 Phase 2 Alzheimer's Disease Trial60%

see_also📖CELF2 Gene60%

see_also📖Temporal Cortex Neurons in Alzheimer's Disease60%

see_also📖Ferulic Acid Carbamate Derivatives for Alzheimer's Dise60%

see_also📖Ubiquitin C-terminal Hydrolase L1 (UCH-L1)60%

see_also📖nct02605785-tau-pet-psp60%

see_also📖NOTCH3 — Notch Receptor 360%

see_also📖OSMR Gene60%

see_also📖DLB Cognitive Fluctuation Mechanisms60%

see_also📖CHMP3 — Charged Multivesicular Body Protein 360%

see_also📖Dentate Gyrus Granule Cells in Alzheimer's Disease60%

see_also📖HNRNPA2B1 - Heterogeneous Nuclear Ribonucleoprotein A2/B160%

see_also📖HEXA (Redirect)60%

see_also📖LY-3372689 LOTUS Trial - Phase 2 in Progressive Supranuclear60%

see_also📖Innate Immune Signaling Pathways in Alzheimer's Disease60%

see_also📖SLC12A5 — Solute Carrier Family 12 Member 5 (KCC2)60%

see_also📖TTYP01 Phase 2 Alzheimer's Disease Trial60%

see_also📖Sleep Disruption in Alzheimer's Disease60%

see_also📖HDAC4 Protein60%

see_also📖TBC1D24 Gene60%

see_also📖ACTN2 — Actinin Alpha 260%

see_also📖slc32a160%

see_also📖UNG Gene60%

see_also📖Lactococcus lactis CKDB001 for Alzheimer's Disease (NCT60%

see_also📖PSP Canada60%

see_also📖Tilavonemab PSP Trial Failure Analysis60%

see_also📖Visual Hallucinations in Dementia With Lewy Bodies60%

see_also📖Stathmin-2** is a protein. This page describes its structure60%

see_also📖DTI White Matter Changes in CBS/PSP60%

see_also📖DLB Autonomic Dysfunction Pathway60%

see_also📖PLP1 Protein60%

see_also📖Locus Coeruleus Noradrenergic Neurons in Alzheimer's Di60%

see_also📖DNAJC2 - DnaJ Heat Shock Protein Family Member C260%

see_also📖SMN1 - Survival Motor Neuron 160%

see_also📖SRRM2 — Serine/Arginine Repetitive Matrix 260%

see_also📖vcam160%

see_also📖trim260%

see_also📖RELN Gene60%

see_also📖BIIB080 (MAPTRx) ASO Therapy for PSP60%

see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%

see_also📖Cholinergic Hypothesis in Alzheimer's Disease60%

see_also📖atg10160%

see_also📖Vascular Contributions to Alzheimer's Disease60%

see_also📖DLB Cure Roadmap60%

see_also📖GRIA3 Protein60%

see_also📖Age-Sensitive Cortical Vulnerability in Parkinson's Dis60%

see_also📖XTR006 Tau PET for Alzheimer's Disease (NCT07115238)60%

see_also📖RAB1A — Ras-Related Protein Rab-1A60%

see_also📖RO7812653 for Early Symptomatic Alzheimer's Disease60%

see_also📖GSR — Glutathione Reductase60%

see_also📖Experiment: Autoimmune Hypothesis Testing in AD60%

see_also📖Davunetide (AL-108) PSP Trial60%

see_also📖PSP Australia60%

see_also📖Locus Coeruleus Norepinephrine in AD60%

see_also📖Hormone Neuroprotection in CBS/PSP60%

see_also📖Neurodegeneration60%

see_also📖PILRB Gene60%

see_also📖PLP1 Gene60%

see_also📖Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri60%

see_also📖PSP Association UK60%

see_also📖Exosome-Mediated Tau Propagation in Progressive Supranuclear60%

see_also📖Neuroligin-1 Protein60%

see_also📖PSP Netherlands — PSP Vereniging Nederland60%

see_also📖Nestin Protein60%

see_also📖FNP-223 PROSPER Trial - Phase 2 in Progressive Supranuclear 60%

see_also📖Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 60%

see_also📖Microglial State Trajectory from Mobilization to Dysregulati60%

see_also📖Survival Motor Neuron (SMN)60%

see_also📖HSPA1B — Heat Shock Protein 70 Family Member 1B60%

see_also📖UCB0107 for Progressive Supranuclear Palsy60%

see_also📖PSP France60%

see_also📖PSP Gene - Persephin60%

see_also📖acetylcholine60%

see_also📖Neuropsychological Testing in CBS and PSP60%

see_also📖Combination Biomarker Panels for Alzheimer's Disease60%

see_also📖PSP Rating Scale (PSPRS)60%

see_also📖NCT04840979 - Genetic Variants Affecting Microglial Activati60%

see_also📖Subthalamic Nucleus Neurons in Progressive Supranuclear Pals60%

see_also📖RAB8A — RAB8A, Member RAS Oncogene Family60%

see_also📖ACTB Gene60%

see_also📖ran60%

see_also📖Lysosomal Dysfunction in Neurodegeneration60%

see_also📖NPTXR — Neuronal Pentraxin Receptor60%

see_also📖HTRA1 Gene60%

see_also📖Eye Tracking and Saccade Testing in Progressive Supranuclear60%

see_also📖section-242-advanced-stem-cell-therapy-neuronal-replacement-60%

see_also📖integrin-ecm-signaling-cbs-psp60%

see_also📖GRM3 — Glutamate Metabotropic Receptor 360%

see_also📖section-155-art-therapy-creative-arts-therapies-cbs-psp60%

see_also📖Benfotiamine Phase 2 Alzheimer's Disease Trial (NCT062260%

see_also📖Alpha-Synuclein Prion-Like Propagation in DLB60%

see_also📖Lecanemab (Leqembi)60%

see_also📖AMX0035 for Progressive Supranuclear Palsy60%

see_also📖protective-strategies-cbs-psp60%

see_also📖PSP Scandinavia60%

see_also📖Memantine - NMDA Antagonist for Alzheimer's Disease60%

see_also📖nestin60%

see_also📖NCT07138677: MCI Network Guided TMS for Early Alzheimer'60%

see_also📖Heterogeneous Nuclear Ribonucleoprotein A2/B1 (HNRNPA2B1)60%

see_also📖BECN1 Gene60%

see_also📖TOLLIP — Toll-Interacting Protein60%

see_also📖DLB Knowledge Gaps60%

see_also📖SYN2 Gene60%

see_also📖SCFA-Mediated Neuroinflammation in Alzheimer's Disease60%

see_also📖Typhaneoside for Progressive Supranuclear Palsy60%

see_also📖Brainstem Circuit Modulation for PSP60%

see_also📖Layer 2 Entorhinal Cortex Neurons in Alzheimer Disease60%

see_also📖pharmacogenomics-cbs-psp60%

see_also📖LY-3372689 MAGNOLIA Trial - Phase 2 in Alzheimer's Dise60%

see_also📖CRISPR Gene Correction Approaches for CBS/PSP60%

see_also📖Endothelial Dysfunction in Vascular Dementia60%

see_also📖AMDX-2011P Phase 2 Trial for Alzheimer's Disease60%

see_also📖txnip60%

see_also📖PSP Spain — Asociación Española de PSP60%

see_also📖Selective Neuronal Vulnerability in Progressive Supranuclear60%

see_also📖Nigral Microglia in Progressive Supranuclear Palsy60%

see_also📖gv1001-psp60%

see_also📖SUMO2 — Small Ubiquitin-Like Modifier 260%

see_also📖dlb-cognitive-fluctuation-mechanisms60%

see_also📖Progressive Supranuclear Palsy (PSP)60%

see_also📖GRIN2A Gene60%

see_also📖N-of-1 Clinical Trial Design for CBS/PSP60%

see_also📖psilocybin-neuropsychiatric-ad60%

see_also📖Entorhinal Cortex Layer II Neurons in Alzheimer's Disea60%

see_also📖First-in-Human 4R Tau Ligand Study in PSP60%

see_also📖Axonal Transport Dysfunction in Progressive Supranuclear Pal60%

see_also📖KCNJ2 — Kir2.1 Inward Rectifier Potassium Channel60%

see_also📖AT(N) Biomarker Classification for Alzheimer's Disease60%

see_also📖Syde® Digital Endpoints for PSP (NCT07389018)60%

see_also📖Gabapentin Enacarbil Phase 4 Trial - Nighttime Agitation60%

see_also📖pde4b60%

see_also📖section-181-advanced-music-rhythm-therapy-cbs-psp60%

see_also📖Cholinergic Basal Forebrain Neurons in Alzheimer's Dise60%

see_also📖Tirzepatide and Dual GIP/GLP-1 Agonists for Neurodegeneratio60%

see_also📖Computational Models of Tau Propagation in Progressive Supra60%

see_also📖Neuronal Death Pathways in Alzheimer's Disease60%

see_also📖NT5E Gene60%

see_also📖Sleep Biomarkers for CBS and PSP60%

see_also📖stathmin60%

see_also📖SPP1 Gene60%

mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%

mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%

mentions🧪Circadian-Synchronized LRP1 Pathway Activation50%

mentions🧪CYP46A1 Overexpression Gene Therapy50%

mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%

mentions🧪HDAC3-Selective Inhibition for Clock Reset50%

mentions🧪Prefrontal sensory gating circuit restoration via PV interne50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%

mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪TREM2-Dependent Microglial Senescence Transition50%

mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%

mentions🧪Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat50%

mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%

mentions🧪Circadian Clock-Autophagy Synchronization50%

mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%

mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%

mentions🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection50%

mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%

mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%

mentions🧪Cryptic Exon Silencing Restoration50%

mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%

mentions🧪Axonal RNA Transport Reconstitution50%

mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%

mentions🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A50%

mentions🧪Ephrin-B2/EphB4 Axis Manipulation50%

mentions🧪RNA Granule Nucleation Site Modulation50%

mentions🧪Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics50%

mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%

mentions🧪Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar50%

mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%

mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%

mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%

mentions🧪Lysosomal Membrane Repair Enhancement50%

mentions🧪Ocular Immune Privilege Extension50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Extracellular Matrix Stiffness Modulation50%

mentions🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam50%

mentions🧪Smartphone-Detected Motor Variability Correction50%

mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%

mentions🧪Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu50%

mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 50%

mentions🧪PARP1 Inhibition Therapy50%

mentions🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli50%

mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%

mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%

mentions🧪Circadian-Synchronized Proteostasis Enhancement50%

mentions🧪Mechanosensitive Ion Channel Reprogramming50%

mentions🧪Enteric Nervous System Prion-Like Propagation Blockade50%

mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%

mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%

mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%

mentions🧪APOE-Mediated Synaptic Lipid Raft Stabilization50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪Mitochondrial RNA Granule Rescue Pathway50%

mentions🧪Arginine Methylation Enhancement Therapy50%

mentions🧪Orexin-Microglia Modulation Therapy50%

mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%

mentions🧪Netrin-1 Gradient Restoration50%

mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%

mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%

mentions🧪Stress Granule Phase Separation Modulators50%

mentions🧪LRP1-Dependent Tau Uptake Disruption50%

mentions🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration50%

mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%

mentions🧪Complement C1q Mimetic Decoy Therapy50%

mentions🧪Synaptic Vesicle Tau Capture Inhibition50%

mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors50%

mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%

mentions🧪VCP-Mediated Autophagy Enhancement50%

mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway50%

mentions🧪Trans-Synaptic Adhesion Molecule Modulation50%

mentions🧪Epigenetic Memory Erasure via TET2 Activation50%

mentions🧪SASP-Mediated Cholinergic Synapse Disruption50%

mentions🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio50%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%

mentions🧪Proteostasis Enhancement via APOE Chaperone Targeting50%

mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%

mentions🧪Senescence-Associated Myelin Lipid Remodeling50%

mentions🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation50%

mentions🧪Digital Twin-Guided Metabolic Reprogramming50%

mentions🧪APOE-TREM2 Interaction Modulation50%

mentions🧪APOE Isoform Conversion Therapy50%

mentions🧪R-Loop Resolution Enhancement Therapy50%

mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%

mentions🧪Autophagosome Maturation Checkpoint Control50%

mentions🧪Complement-Mediated Synaptic Pruning Dysregulation50%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi50%

mentions🧪Lysosomal Enzyme Trafficking Correction50%

mentions🧪Blood-Brain Barrier SPM Shuttle System50%

mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%

mentions🧪Mitochondrial-Lysosomal Contact Site Engineering50%

mentions🧪Senescent Cell Mitochondrial DNA Release50%

mentions🧪Low Complexity Domain Cross-Linking Inhibition50%

mentions🧪Piezoelectric Nanochannel BBB Disruption50%

mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%

mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%

mentions🧪HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor50%

mentions🧪Sleep Spindle-Synaptic Plasticity Enhancement50%

mentions🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon50%

mentions🧪Glial Glycocalyx Remodeling Therapy50%

mentions🧪Reelin-Mediated Cytoskeletal Stabilization Protocol50%

mentions🧪Senescence-Induced Lipid Peroxidation Spreading50%

mentions🧪TREM2-mediated microglial tau clearance enhancement50%

mentions🧪Ganglioside Rebalancing Therapy50%

mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement50%

mentions🧪Glycine-Rich Domain Competitive Inhibition50%

mentions🧪Senescence-Activated NAD+ Depletion Rescue50%

mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%

mentions🧪Complement C1q Subtype Switching50%

mentions🧪Lysosomal Calcium Channel Modulation Therapy50%

mentions🧪Pharmacological Enhancement of APOE4 Glycosylation50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪Cross-Seeding Prevention Strategy50%

mentions🧪Nucleolar Stress Response Normalization50%

mentions🧪APOE-Dependent Autophagy Restoration50%

mentions🧪Gut Barrier Permeability-α-Synuclein Axis Modulation50%

mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%

mentions🧪Extracellular Vesicle Biogenesis Modulation50%

mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%

mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%

mentions🧪Purinergic Signaling Polarization Control50%

mentions🧪Multi-Modal Stress Response Harmonization50%

mentions🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro50%

mentions🧪Phase-Separated Organelle Targeting50%

mentions🧪Transcriptional Autophagy-Lysosome Coupling50%

mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%

mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%

mentions🧪Transglutaminase-2 Cross-Linking Inhibition Strategy50%

mentions🧪Complement C1QA Spatial Gradient in Cortical Layers50%

mentions🧪Vagal Afferent Microbial Signal Modulation50%

mentions🧪Retinal Vascular Microcirculation Rescue50%

mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%

mentions🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro50%

mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors50%

mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides50%

related🧪PARP1 Inhibition Therapy40%

related🧪Complement C1q Subtype Switching40%

related🧪Ganglioside Rebalancing Therapy40%

related🧪Netrin-1 Gradient Restoration40%

mentions🔬What are the mechanisms underlying sleep disruption as cause35%

mentions🔬What are the mechanisms underlying digital biomarkers and ai35%

mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di35%

mentions🔬What are the mechanisms underlying what are the mechanisms b35%

mentions🔬What are the mechanisms underlying senolytic therapy for age35%

mentions🔬What are the mechanisms underlying microglia-astrocyte cross35%

mentions🔬What are the mechanisms underlying apoe4 structural biology 35%

mentions🔬What gene expression changes in the aging mouse brain predic35%

mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp35%

mentions🔬What are the mechanisms underlying synaptic pruning by micro35%

mentions🔬Investigate prion-like spreading of tau pathology through co35%

mentions🔬What are the mechanisms underlying mitochondrial transfer be35%

mentions🔬Epigenetic reprogramming in aging neurons35%

mentions🔬What are the mechanisms underlying tdp-43 phase separation t35%

mentions🔬Analyze circuit-level changes in neurodegeneration using All35%

mentions🔬How does metabolic reprogramming (glucose metabolism shifts,35%

mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc35%

mentions🔬What are the mechanisms underlying perivascular spaces and g35%

mentions🔬What are the mechanisms underlying protein aggregation cross35%

mentions🔬What are the mechanisms underlying astrocyte reactivity subt35%

mentions🔬What are the mechanisms underlying neuroinflammation resolut35%

mentions🔬Investigate how lipid raft composition (cholesterol metaboli35%

mentions🔬What are the mechanisms underlying epigenetic clocks and bio35%

mentions🔬What are the mechanisms underlying rna binding protein dysre35%

mentions🔬What are the mechanisms underlying mechanistic role of apoe 35%

mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa35%

mentions🔬What are the mechanisms underlying selective vulnerability o35%

mentions🔬What are the mechanisms underlying blood-brain barrier trans35%

mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas35%

Dementia Australia

💬 Discussion